期刊文献+

RNA干扰her2/neu基因表达抑制肺癌A549细胞增殖的研究 被引量:9

Inhibition of A549 cell proliferation by RNA interfered gene her2/neu
下载PDF
导出
摘要 目的:HER2/neu表达对肺癌细胞生物学的影响尚不明了,文中运用RNA干扰技术抑制HER2/neu表达,并观察对肺癌A549细胞体外增殖的影响。方法:构建针对her2/neu基因的RNA干扰真核表达载体,运用脂质体介导转染A549细胞并用G418筛选出阳性克隆株;半定量RT-PCR和Western检测转染后HER2/neu mRNA及蛋白的表达水平;FCM检测细胞周期分布;MTT法绘制细胞生长曲线观察体外细胞的增值能力。结果:成功构建针对her2/neu基因的RNA干扰真核表达载体(命名为psilence3.1-HER2),转染后使A549细胞HER2/neu mRNA和蛋白的表达较未转染组和阴性对照质粒转染组均显著下调;细胞G0/G1期细胞增加,S期细胞减少;细胞生长曲线右移、增殖速度明显减慢。结论:psilence3.1-HER2能够稳定、高效、特异地抑制肺癌A549内her2/neu基因的表达,可显著抑制细胞增殖。针对her2/neu基因的RNAi策略有望成为肺癌的基因治疗的新选择。 Objective: The effect of HER2/neu expression on the proliferation of A549 cell is not clear. We inhibited the HER2/neu expression with RNA interference (RNAi) technique, and investigated the proliferation of A549 cell in this study. Methods: Firstly a recombinant RNAi expression plasmid targeting to her2/neu gene ( named psilence 3.1-HER2) was constructed. After RNAi plasmids being transfected to A549 cells with Lipofectamine, the positive clones were screened with G418. The expression changes of HER2/neu mRNA and protein were evaluated with RT-PCR and Western Blot respectively; Also FCM analysis, MTF method were applied to measure cell cycle, cell growth of A549 cell respectively after the transfection of psilence 3.1-HER2. Results: The psilence 3.1-HER2 was successfully constructed and can specially inhibit HER2/neu mRNA and protein expression after transfection. FCM results showed that cells transfected with psilence 3.1-HER2 increased accumulation of cells in G0/G1 phase with a decrease in the percentage of cells in S-phase, and the growth curve of cells exhibited slower proliferation. Conclusion: The psilence 3. 1-HER2 can knockdown her2/neu gene specially and efficiently, transfection of psilence 3.1-HER2 contributes to the depression of A549 cell proliferation. The data described here provided a proof of the concept that vector-based RNAi targeting to her2/neu gene could be used therapeutically for lung cancer.
出处 《医学研究生学报》 CAS 2009年第3期236-239,243,共5页 Journal of Medical Postgraduates
基金 江苏省医学重点人才基金资助项目(批准号:R2007113) 中国博士后科学基金项目(批准号:20070411050) 江苏省博士后科研资助计划项目(批准号:0701023B)
关键词 HER2/NEU RNA干扰 A549细胞 细胞增殖 HER2/neu RNA interference A549 cell Cell proliferation
  • 相关文献

参考文献11

  • 1曾志武,易继林.HER-2/neu基因在肿瘤组织中的表达及其临床价值[J].消化外科,2003,2(3):221-224. 被引量:7
  • 2Tapia C, Savic S, Wagner U, et al. HER2 gene status in primary breast cancers and matched distant metastases [ J ]. Breast Cancer Res, 2007,9 ( 3 ) :31-35.
  • 3Menard S, Casalini P, Campiglio M, et al. HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer [ J ]. Ann Oncol, 2001,12 (S1) :15-19.
  • 4Oshima RG, Lesperance J, Munoz V, et al. Angiogenic acceleration of Neu induced mammary tumor progression and metastasis [J]. Cancer Res, 2004, 64(1):169-179.
  • 5Shi D,He G, Cao S, et al. Overexpression of the c - erbB- 2 / neu-encoded P185 protein in primary lung caner[ J]. Mol Carcinog, 1992, 5(3) :213- 218.
  • 6Hirsch FR, Langer CJ. The role of HER2/neu expression and trastuzumab in non-small cell lung cancer [ J]. Senfin Oncol, 2004 ,31 ( S1 ) :75-82.
  • 7Hirseh FR, Varella-Garcia M, Cappuzzo F, et al. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib [ J ]. Ann Oncol, 2007, 18 (4) :752-760.
  • 8纪振钢,裘秀春,杨彤涛,龙华,马保安,周勇,张明华,许彦鸣,杨安钢,范清宇.HER2靶向重组截短型Bid片段融合蛋白对骨肉瘤细胞的促凋亡作用[J].医学研究生学报,2007,20(2):120-122. 被引量:1
  • 9Heinmoller P, Gross C, Beyser K, et al. HER2 status in nonsmall cell lung cancer: results from patient screening for enrollment to a phase Ⅱ study of herceptin [ J ]. Clin Cancer Res, 2003, 9(14) :5238-5243.
  • 10金志良,孙新臣,成红艳,魏青,何少忠.人高迁移率族蛋白组A1基因RNA干扰慢病毒载体的构建与鉴定[J].医学研究生学报,2008,21(5):468-471. 被引量:6

二级参考文献24

共引文献11

同被引文献98

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部